cannabis industry
cannabis industry · page 78
- Opinion
‘The European Cannabis Industry Has Passed The Point Of No Return’
In a Q&A with BusinessCann looking ahead to 2022 Lino Cereghetti, Chief Operating Officer at Swiss company Pure Holding says it is only a matter of time before other countries follow Germany with progressive regulations BC: What developments should we expect to see in the European cannabis industry in 2022?
- Medical
Glass Pharms: initiating domestic supply of medical cannabis in the UK
Glass Pharms will begin the domestic supply of medical cannabis in the UK from the world’s first carbon-negative cannabis cultivation facility.
- CBD Market
British Cannabis to power Elixinol CBD range
Australia’s leading global CBD range, Elixinol, is to be ‘powered by British Cannabis’ in the UK under an exclusive new agreement.
- CBD Market
ACMD releases new advice on THC levels in consumer CBD products
The report suggests that the dose of each cannabinoid should not exceed 50 micrograms.
- Uncategorized
Canopy Growth sells cannabinoid company to Germany’s Dermapharm
Canopy Growth Corporation has entered into an agreement to sell its cannabinoid subsidiary.
- Hemp Industry
Herbotany Health on how hemp could help with climate change.
“Hemp is a very sustainable and ecologically friendly plant. You cannot just leave the plant on its own as you have to do work to it in the process of farming to make it sustainable.”
- Medical
Materia Malta begins its first European medical cannabis sales
The company’s medical cannabis flower is now available in Malta pharmacies.
- Your #1 Podcast on Cannabis News
How New York’s legalization affects the industry’s path forward
Adjacent to Business of Cannabis event in New York City on December 9th, we were able to connect with New York-based business owners, operators, investors and thought-leaders.
- Pharmaceutical
Pfizer enters medical cannabis market with new acquisition
Pharma titan Pfizer is to acquire Arena Pharmaceuticals which has a pipeline in cannabinoid therapeutics.
- Adult-Use
Looking back on the cannabis industry in 2021
2021 has been a good year for the cannabis industry, says the new Brightfield Group report.
- CBD Market
CBD-based smoking cessation formula close to patent approval
Kanabo has moved one step closer to patent approval and called for the UK to set up CBD inhalation regulation.
- Medical
Portfolio of doseable cannabis products launched in the UK
The products will allow patients to administer metered doses of their medicines.
